James Spellman

442 total citations
10 papers, 351 citations indexed

About

James Spellman is a scholar working on Oncology, Infectious Diseases and Epidemiology. According to data from OpenAlex, James Spellman has authored 10 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 2 papers in Infectious Diseases and 2 papers in Epidemiology. Recurrent topics in James Spellman's work include Global Cancer Incidence and Screening (3 papers), Colorectal Cancer Screening and Detection (2 papers) and Hepatitis C virus research (2 papers). James Spellman is often cited by papers focused on Global Cancer Incidence and Screening (3 papers), Colorectal Cancer Screening and Detection (2 papers) and Hepatitis C virus research (2 papers). James Spellman collaborates with scholars based in United Kingdom, India and Iran. James Spellman's co-authors include John M. Yuhas, Filip Čulo, Scott W. Jordan, Shahbaz Afzal, Anastasios Kanatas, K. Rajender Reddy, Stefan Zeuzem, Christoph Sarrazin, Michael P. Manns and Sophia Lu and has published in prestigious journals such as Gastroenterology, British Journal of Cancer and British Journal of Oral and Maxillofacial Surgery.

In The Last Decade

James Spellman

10 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Spellman United Kingdom	3	155	96	87	86	56	10	351
Fundagül Andiç Türkiye	10	78 0.5×	69 0.7×	52 0.6×	68 0.8×	103 1.8×	22	347
Waldemar M. Przybyszewski Poland	12	213 1.4×	153 1.6×	39 0.4×	127 1.5×	62 1.1×	31	417
Raghu Venkatramanamoorthy United States	11	67 0.4×	128 1.3×	268 3.1×	176 2.0×	89 1.6×	20	528
Xianwen Zhao China	10	31 0.2×	179 1.9×	184 2.1×	87 1.0×	141 2.5×	15	582
Rakesh Dhankhar India	9	19 0.1×	125 1.3×	74 0.9×	63 0.7×	57 1.0×	36	363
J.P. Pilkington Woll Spain	11	153 1.0×	49 0.5×	28 0.3×	82 1.0×	55 1.0×	35	354
Christian Weißenberger Germany	8	36 0.2×	77 0.8×	106 1.2×	52 0.6×	30 0.5×	12	348
Alberto Bonetta Italy	10	125 0.8×	43 0.4×	71 0.8×	250 2.9×	60 1.1×	25	383
Carlos Nobre Leitão Portugal	13	49 0.3×	137 1.4×	116 1.3×	50 0.6×	41 0.7×	16	495
Kevin P. Hieber United States	12	375 2.4×	178 1.9×	60 0.7×	126 1.5×	95 1.7×	13	553

Countries citing papers authored by James Spellman

Since Specialization

Citations

This map shows the geographic impact of James Spellman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Spellman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Spellman more than expected).

Fields of papers citing papers by James Spellman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Spellman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Spellman. The network helps show where James Spellman may publish in the future.

Co-authorship network of co-authors of James Spellman

This figure shows the co-authorship network connecting the top 25 collaborators of James Spellman. A scholar is included among the top collaborators of James Spellman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Spellman. James Spellman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Kanatas, Anastasios, et al.. (2023). Follow-up arrangements in head and neck cancer clinics during the COVID-19 pandemic: results from two tertiary UK head and neck cancer centres. Annals of The Royal College of Surgeons of England. 105(S2). S60–S68. 1 indexed citations

Cairns, John, James Spellman, & Anastasios Kanatas. (2020). Attendance at a one-off screening clinic for head and neck cancer during Cancer Awareness Week. British Journal of Oral and Maxillofacial Surgery. 58(9). e1–e2. 1 indexed citations

Chuang, Wan‐Long, Tsung‐Hui Hu, Peter Buggisch, et al.. (2019). Tu1501 – Ledipasvir/Sofosbuvir for 8, 12, Or 24 Weeks is Safe and Effective in Patients Undergoing Dialysis. Gastroenterology. 156(6). S–1344. 1 indexed citations

Flamm, Steven L., Eric Lawitz, Brian B. Borg, et al.. (2019). 953 – High Efficacy and Improvement in Cpt Class with Sofosbuvir/Velpatasvir Plus Ribavirin for 12 Weeks in Patients with Cpt C Decompensated Cirrhosis. Gastroenterology. 156(6). S–1219. 2 indexed citations

Spellman, James, et al.. (2017). Timeliness of Breast Cancer Treatment in Delaware. Delaware Journal of Public Health. 3(3). 80–87. 1 indexed citations

Reddy, K. Rajender, Michael P. Manns, Kris V. Kowdley, et al.. (2017). No Impact of Rass on the High Efficacy of SOF/VEL/VOX for 12 Weeks in Daa-Experienced Patients: An Integrated Resistance Analysis of the Polaris-1 and Polaris-4 Studies. Gastroenterology. 152(5). S1062–S1062. 1 indexed citations

Spellman, James, et al.. (2013). Feasibility of using central registry data to assess timeliness of breast cancer care in Delaware.. PubMed. 40(4). 151–8. 2 indexed citations

Spellman, James, et al.. (1988). Acute pulmonary histoplasmosis outbreak following home renovation.. PubMed. 37(6). 457–60. 8 indexed citations

Yuhas, John M., et al.. (1980). Treatment of tumours with the combination of WR-2721 and cis-dichlorodiammineplatinum (II) or cyclophosphamide. British Journal of Cancer. 42(4). 574–585. 92 indexed citations

10.

Yuhas, John M., James Spellman, & Filip Čulo. (1980). The role of WR-2721 in radiotherapy and/or chemotherapy.. PubMed. 3(3). 211–6. 242 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact